BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Treatment
62 results:

  • 1. A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.
    Yang Y; Yi Y; Wang Z; Li S; Zhang B; Sang Z; Zhang L; Cao Q; Li B
    BMC Cancer; 2024 Apr; 24(1):460. PubMed ID: 38609892
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study.
    Kim DW; Chul Cho B; Pachipala K; Kim SW; Wang CL; Chang GC; Ahn MJ; Alvarez R; Chiu CH; Trigo J; Estival A; Karam SD; O'Brien C; Gowda H; Jiang H; Bauman JE
    Lung Cancer; 2024 Apr; 190():107530. PubMed ID: 38471416
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. FABP6 serves as a new therapeutic target in esophageal tumor.
    Zhang D; Zhao F; Liu H; Guo P; Li Z; Li S
    Aging (Albany NY); 2024 Jan; 16(2):1640-1662. PubMed ID: 38277205
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparison of HASTE versus EPI-Based DWI for Retinoblastoma and Correlation with Prognostic Histopathologic Parameters.
    Sharma M; Gupta A; Jana M; Kashyap S; Bakhshi S; Sharma S
    AJNR Am J Neuroradiol; 2024 Feb; 45(2):198-204. PubMed ID: 38176729
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON).
    Garon EB; Cho BC; Luft A; Alatorre-Alexander J; Geater SL; Kim SW; Ursol G; Hussein M; Lim FL; Yang CT; Araujo LH; Saito H; Reinmuth N; Medic N; Mann H; Shi X; Peters S; Mok T; Johnson M
    Lung Cancer; 2023 Dec; 186():107422. PubMed ID: 37992595
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Development of programs to predict the occurrence of mucositis from digital imaging and communications in medicine data by machine learning in head and neck volumetric modulated radiotherapy.
    Rachi T; Ariji T; Takahashi S
    J Appl Clin Med Phys; 2023 Dec; 24(12):e14125. PubMed ID: 37602786
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Risk assessment of venous thromboembolism in head and neck cancer patients and its establishment of a prediction model.
    Li CX; He Q; Wang ZY; Fang C; Gong ZC; Zhao HR; Ling B
    Head Neck; 2023 Oct; 45(10):2515-2524. PubMed ID: 37548087
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Single-cell RNA sequencing reveals the heterogeneity and microenvironment in one adenoid cystic carcinoma sample.
    An PG; Wu WJ; Tang YF; Zhang J
    Funct Integr Genomics; 2023 May; 23(2):155. PubMed ID: 37162576
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Evaluation of sarcopenia and sarcopenic obesity in patients affected by oral squamous cell carcinoma: A retrospective single-center study.
    Bonavolontà P; Improta G; Dell'Aversana Orabona G; Goglia F; Abbate V; Sorrentino A; Piloni S; Salzano G; Iaconetta G; Califano L
    J Craniomaxillofac Surg; 2023 Jan; 51(1):7-15. PubMed ID: 36739189
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic Benefit of Additional treatment After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma.
    Takahashi S; Hatta W; Watanabe K; Koike T; Shimada T; Hikichi T; Toya Y; Tanaka I; Onozato Y; Hamada K; Fukushi D; Watanabe K; Kayaba S; Ito H; Mikami T; Oikawa T; Takahashi Y; Kondo Y; Yoshimura T; Shiroki T; Nagino K; Hanabata N; Funakubo A; Hirasawa D; Ohira T; Nakamura J; Nakamura T; Nakaya N; Matsumoto T; Fukuda S; Masamune A; Iijima K
    Dig Dis Sci; 2023 May; 68(5):2050-2060. PubMed ID: 36445654
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study.
    Wang G; Huang C; Yang K; Guo R; Qiu Y; Li W; Mao Y; Tang L; Ma J
    Radiother Oncol; 2022 Dec; 177():205-213. PubMed ID: 36375564
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Attention-aware 3D U-Net convolutional neural network for knowledge-based planning 3D dose distribution prediction of head-and-neck cancer.
    Osman AFI; Tamam NM
    J Appl Clin Med Phys; 2022 Jul; 23(7):e13630. PubMed ID: 35533234
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Preoperative comprehensive malignancy risk estimation for thyroid nodules: Development and verification of a network-based prediction model.
    Shao G; Sun B; Shi M; Song Y; Sun Z; Hao X; Li L; Fu Z
    Eur J Surg Oncol; 2022 Jun; 48(6):1264-1271. PubMed ID: 35367109
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Analysis of correlation factors influencing the outcome of initial 131I remnant ablative therapy in intermediate- to high-risk patients with papillary thyroid microcarcinoma.
    Wu R; Liu W; Li N; Wang X; Sun D; Ji Y; Jia Q; Tan J; Zheng W
    Nucl Med Commun; 2022 Jun; 43(6):669-674. PubMed ID: 35351838
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Could Urinary Iodine Be an Effective Predictive Factor for Thyroid cancer After High Dose Radioactive Iodine Therapy?
    Cao J; Yun C; Zhu X; Sun Y; Li X; Zhang W
    Endocr Pract; 2022 Jun; 28(6):586-592. PubMed ID: 35304327
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Changes in the Sphenoid Bone Encountered During the Endoscopic Endonasal Transsphenoidal Approach.
    Jeong CY; Hong YK; Jeun SS; Park JS; Kim SW; Cho JH; Park YJ; Kim DH; Kim SW
    Laryngoscope; 2022 May; 132(5):965-972. PubMed ID: 35112725
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Isothermal Amplification AmpFire Assay for Human Papillomavirus (HPV) Detection and Genotyping in Formalin-Fixed, Paraffin-Embedded Oropharyngeal cancer Samples.
    Paytubi S; Taberna M; Mena M; Quirós B; Gomà M; Alemany L; Bosch FX; Pavón MÁ
    J Mol Diagn; 2022 Jan; 24(1):79-87. PubMed ID: 34801703
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prediction model for cervical lymph node metastasis in human papillomavirus-related oropharyngeal squamous cell carcinomas.
    Joo L; Bae YJ; Choi YJ; Lee YS; Chung SR; Suh CH; Kim SO; Baek JH; Lee JH
    Eur Radiol; 2021 Oct; 31(10):7429-7439. PubMed ID: 33779817
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Do Red Blood Cell Transfusions Influence Long-Term Outcomes in Patients Undergoing Primary Surgery for Oral Squamous Cell Carcinoma?
    Brandenburg LS; Schwarz SJ; Weingart JV; Metzger MC; Fuessinger MA; Ermer MA
    J Oral Maxillofac Surg; 2021 Jul; 79(7):1570-1579. PubMed ID: 33675703
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ cancer of the Oropharynx.
    Waddle MR; Ma DJ; Visscher SL; Borah BJ; May JM; Price KA; Moore EJ; Patel SH; Hinni ML; Chintakuntlawar AV; Garcia JJ; Graner DE; Neben-Wittich MA; Garces YI; Hallemeier CL; Price DL; Kasperbauer JL; Janus JR; Foote RL; Miller RC
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):396-402. PubMed ID: 33359567
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.